FMC stock had a horrible day after issuing dismal financial guidance. Investors might not want to go bargain-bin shopping just yet.
On Thursday, FMC said it expects third-quarter sales of $65 million to $125 million and adjusted earnings before interest, taxes, depreciation, and amortization (Ebitda) of negative $565 million to negative $510 million. Wall Street was expecting sales of $869 million and Ebitda of $133 million.
The scale of the miss is hard to understand. Investors certainly struggled to make sense of it. Shares fell almost 31% to $5.62 on Thursday. The stock traded as low as $4.84.
The issue seems to boil down to high channel inventory that distributors cannot sell at current market prices. Discounts were necessary.
Now, the stock trades for about seven times estimated 2027 Ebitda. A couple of years ago, shares traded for closer to 10 times.
The price might look attractive, but peer Corteva shares trade for about six times Ebitda. And Corteva doesn't have much net debt after its spinoff of the Vylor seed business. FMC has significant debt, more than five times expected 2027 Ebitda. That's a lot. Industrial companies in the S&P 500 have less than two times on average.
Corteva looks like the better bet right now, according to Wall Street. Only 20% of analysts covering FMC stock rate its shares Buy, according to FactSet. The average Buy-rating ratio for S&P 500 stocks typically ranges from 55% to 60%. The Buy-rating ratio for Corteva stock is 78%.
There are probably more charges to come at FMC, says Citi analyst Patrick Cunningham.
"After catching up with [FMC] the company, we learned that slower-moving higher-priced FMC products are representing an increasing portion of customer inventories. This dynamic was likely to be an overhang for several quarters and limit FMC's ability to sell higher-priced products into the channel, including new products," Cunningham wrote on Friday. "On cash, FMC doesn't see a dramatic impact from the charges in 3Q but will likely lead to receivables write-downs in coming quarters."
There is also an opportunity cost to buying FMC now, says Barron's senior technical analyst Doug Busch. "Over time, maybe next few months [FMC could] fill in that gap from yesterday, a nice percentage move, but there are better fish to fry now," he says.
Busch isn't looking at fundamentals like crop pricing. He is looking at stock charts and market history to understand what investors are thinking. They aren't likely to forget about Thursday's guidance soon.
FMC stock was down 2.94% in morning trading at $5.45. Corteva stock was up 0.74% at $12.96, while S&P 500 and Dow Jones Industrial Average futures were up 0.1%.
Comments